Zeo ScientifiX (ZEOX) EPS (Basic) Growth (3y) (2015 - 2026)
Zeo ScientifiX (ZEOX) EPS (Basic) Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn | 64.84% |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn | 18.44% |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 37.21% |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn | 36.73% |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn | -26.87% |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 67.51% |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | -38.31% |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | 37.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -264.56% |
| Jan 31, 2026 | -326.41% |
| Oct 31, 2025 | -245.23% |
| Jul 31, 2025 | -406.96% |
| Apr 30, 2025 | -448.60% |
| Jan 31, 2025 | -400.89% |
| Oct 31, 2024 | -532.07% |
| Jul 31, 2024 | -429.96% |
| Apr 30, 2024 | -394.12% |
| Jan 31, 2024 | -183.47% |
| Oct 31, 2023 | -190.16% |
| Jul 31, 2023 | 45.80% |
| Apr 30, 2023 | 19.06% |
| Jan 31, 2023 | -5.76% |
| Oct 31, 2022 | -19.73% |
| Jul 31, 2022 | -50.52% |
| Apr 30, 2022 | -13.19% |
| Jan 31, 2022 | -42.32% |
| Oct 31, 2021 | 16.75% |
| Jul 31, 2021 | -19.04% |